Indian shares slipped on Tuesday, with the Sensex falling about 300 points and the Nifty slipping below 24,900 even as PSU bank stocks rose more than 2%, signaling a rotation inside a weak broader market rather than a broad-based panic.
India shares fall as PSU banks rise

The move matters because banks and financials are among the biggest weightings in Indian benchmarks, so strength in PSU lenders can cushion declines even when risk appetite softens elsewhere. A split tape also points to investors favoring domestic cyclicals and state-owned lenders over more expensive or export-sensitive pockets of the market.
In the broader banking pack, the outperformance stands out against a market that remains sensitive to bond yields, policy expectations and liquidity. Standard technical measures on the NSE Bank index show the sector is still elevated, with the index trading well above both its 50-day and 200-day moving averages and RSI readings in overbought territory, suggesting recent gains have been strong even after the latest pullback in the headline benchmark.
Across individual stocks, the day was mixed. GlaxoSmithKline Pharmaceuticals jumped 7.43% to 2,727.60 rupees, Glenmark Pharmaceuticals rose 3.55% to 2,687.05 rupees, and Indian Renewable Energy Development Agency gained 5.93% to 118.09 rupees, while Jubilant FoodWorks dropped 4.74% to 429.90 rupees, Mphasis fell 3.54% to 2,445 rupees and Aegis Vopak declined 3.46% to 256.90 rupees.
Among other notable losers, Torrent Power slid 2.75% to 1,238 rupees, Apar Industries fell 2.57% to 14,205.95 rupees, Dalmia Bharat lost 2.42%, Emcure Pharmaceuticals slipped 2.39% and Jindal Stainless declined 2.25%. Exide Industries, Emami and Supreme Industries were among the broader gainers, rising between 3.06% and 3.28%.
Investors will watch whether PSU bank buying broadens into private lenders and whether the headline indices can recover above key support levels after the Nifty’s drop below 24,900. Sustained outperformance from banks would help stabilize sentiment; continued weakness in heavyweight stocks would leave the market vulnerable to sharper swings.
| Entity | Gains | Losses |
|---|---|---|
| PSU banks | ▲Index outperformance | ▼Broader market weakness |
| Sensex/Nifty | ▲Potential support from banks | ▼Intraday selling pressure |
| GlaxoSmithKline Pharma, Glenmark Pharma, IREDA | ▲Strong price gains | ▼None on the day |
| Jubilant FoodWorks, Mphasis, Aegis Vopak | ▲None on the day | ▼Sharp declines |




